California reservoir water level update as lake surges 6 feet in a day A restaurant announces its closure. Fans line up for hours. Where have they been? New class of warship to be named after ...

Fans of two beloved artists will finally get some satisfaction now that they’ve reached an agreement to release a mash-up of their best-loved songs. English DJ Fatboy Slim announced Friday that ...

We may earn commission from links on this page, but we only recommend products we love. Promise. Whether it was the joy of seeing the pen swirl round and round to create a spiral or all the wild ...

If developing drugs for metabolic dysfunction-associated steatohepatitis (MASH) were a poker game, you could say Novo Nordisk (NASDAQ Copenhagen: NOVO-B) saw a competitor’s bet and raised the stakes ...

Novo Nordisk has struck a deal to buy Akero Therapeutics for up to $5.2 billion, teeing up a showdown with Roche and others in a blockbuster liver disease market. Akero confirmed its status as a key ...

Roche has scooped up 89bio and its phase III FGF21 analogue pegozafermin, as drug developers continue to race to advance new drugs for the liver disease metabolic dysfunction-associated ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — Roche on Thursday said it would buy 89bio, the maker of an ...

Pro Football Hall of Famer and Miami Dolphins legend Dan Marino had a wake-up call in 2007 when he received a personal health diagnosis. Now, he’s sharing his journey to help others who may be ...

The FDA is considering using a noninvasive liver measurement as a surrogate endpoint for certain metabolic dysfunction-associated steatohepatitis (MASH) patients, a move that could speed up drug ...